Billionaire Stanley Druckenmiller Owns $175 Million of This Brilliant Dividend Growth Stock

Stanley Druckenmiller's Duquesne Family Office holds a $175 million position in Philip Morris International (PM), acquired in Q2 2024, which has since returned over 100% driven by growth in smoke-free products like Zyn and Iqos; currently 42% of revenue comes from these alternatives, contributing to $38.4 billion in overall revenue. Despite a lower dividend yield of 3%, Philip Morris's dividend growth is expected to continue, with potential for 10% annual growth over the next five years supported by increasing free cash flow, making it an attractive dividend growth stock despite a forward P/E of 24.

Analysis

Philip Morris International (PM) has garnered significant investor attention, underscored by Stanley Druckenmiller's Duquesne Family Office establishing a $175 million position in Q2 2024, which, according to the article, has subsequently delivered over 100% total return, mirroring the stock's general performance over the last year. This surge is primarily attributed to the company's successful strategic pivot towards smoke-free products; its nicotine pouch brand Zyn has achieved sales exceeding 200 million cans per quarter in the U.S., and the Iqos heat-not-burn device is a category leader in Europe and Japan. These next-generation products now account for a substantial 42% of PM's $38.4 billion in revenue over the past twelve months. Furthermore, the company's predominantly international revenue streams offer a potential hedge against U.S. dollar devaluation. While the current dividend yield is 3%, reflecting the stock's appreciation (and lower than a year ago), with a dividend per share (DPS) of $5.35 funded by a free cash flow (FCF) per share of $6.55, there are strong prospects for dividend growth. FCF per share is projected to expand to $10 or higher within the next five years, even with current FCF depressed by manufacturing investments, potentially supporting approximately 10% annual dividend increases and a future DPS of $8.61. Despite a forward price-to-earnings ratio of 24 following this significant stock appreciation, the article posits this valuation is reasonable for a consistent earnings grower, an outlook that aligns with the provided strongly positive sentiment signals for the company.

Key Decisions for Investors

• Investors could consider Philip Morris International for its demonstrated success in transitioning to high-growth smoke-free products like Zyn and Iqos, which now constitute 42% of revenues, and note the significant endorsement from prominent investors such as Stanley Druckenmiller.
• Evaluate the potential for attractive dividend growth, with company guidance suggesting a capability for 10% annual increases over the next five years driven by an expected rise in free cash flow per share from the current $6.55 to over $10.
• Acknowledge the stock's substantial 100% appreciation over the past year and its forward P/E of 24; while past high returns are unlikely to be replicated annually, the focus should be on long-term market share gains in the evolving nicotine market and sustained earnings growth.
• Closely monitor the ongoing market penetration and volume growth of Zyn and Iqos, alongside the actualization of projected free cash flow improvements, as these are critical factors for sustaining the company's growth trajectory and dividend expansion capabilities.